Pfueller SL, Cosgrove L, Firkin BG, Tew D. Relationship of raised platelet IgG in thrombocytopenia to total platelet protein content. Br J Haematol 1981;49:293–302.10.1111/j.1365-2141.1981.tb07226.x
LoBuglio AF, Court WS, Vinocur L, et al. Immune thrombocytopenic purpura. Use of a 1251-labeled antihuman IgG monoclonal antibody to quantify platelet-bound IgG. N Engl J Med 1983;309:459–63.10.1056/NEJM198308253090804
Shaw GM, Axelson J, Maglott JG, LoBuglio AF. Quantification of platelet-bound IgG by 1251-Staphylococcal protein A in immune thrombocytopenic purpura and other thrombocytopenic disorders. Blood 1984;63:154–61.10.1182/blood.V63.1.154.154
Schiffer CA, Young V. Detection of platelet antibodies using a micro-enzyme-linked immunosorbent assay (ELISA). Blood 1983;61:311–17.10.1182/blood.V61.2.311.311
Horai S, Claas FH, van Rood JJ. Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA). Comparative studies with the indirect immunofluorescence assay. Immunol Lett 1981;3:155–8.10.1016/0165-2478(81)90119-X
Horai S, Claas FH, van Rood JJ. Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA) on artificial monolayers of platelets. Immunol Lett 1981;3:67–72.10.1016/0165-2478(81)90052-3
von dem Borne AE, Verheugt FW, Oosterhof F, et al. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978;39:195–207.10.1111/j.1365-2141.1978.tb01089.x
Ramos RR, Curtis BR, Chaplin H. A latex particle assay for platelet-associated IgG. Transfusion 1992;32:235–8.10.1046/j.1537-2995.1992.32392213807.x1557805
Ogden DM, Asfour A, Koller C, Lichtiger B. Platelet cross-matches of single-donor platelet concentrates using a latex agglutination assay. Transfusion 1993;33:644–50.10.1046/j.1537-2995.1993.33893342745.x8342230
Shibata Y, Juji T, Nishizawa Y, et al. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981;41:25–31.10.1111/j.1423-0410.1981.tb01007.x7324440
Rachel JM, Summers TC, Sinor LT, Plapp FV. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing. Am J Clin Pathol 1988;90:63–8.10.1093/ajcp/90.1.633389344
Furihata K, Nugent DJ, Bissonette A, et al. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest 1987;80:1624–30.10.1172/JCI1132504424322445781
Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722–6.10.1182/blood.V70.6.1722.1722
McMillan R, Tani P, Millard F, et al. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987;70:1040–5.10.1182/blood.V70.4.1040.1040
Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778–81.10.1172/JCI1140823038912565345
Curtis BR, Edwards JT, Hessner MJ, et al. Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood 2000;96:1574–81.10.1182/blood.V96.4.1574
Curtis BR, McFarland JG. Platelet immunology and alloimmunization. In: Simon TL, Dzik WH, Snyder E, et al., eds. Rossi’s principles of transfusion medicine. Philadelphia: Lippincott Williams & Wilkins, 2008:203–17.
Smith GA, Ranasinghe E, Ouwehand WH. The importance of using multiple techniques for detection of platelet antibodies. Vox Sang 2007;93:306–8.10.1111/j.1423-0410.2007.00969.x18070274
Garratty G, Arndt P. Applications of flow cytofluorometry to transfusion science. Transfusion 1995;35:157–78.10.1046/j.1537-2995.1995.35295125739.x7825212
Christopoulos CG, Kelsey HC, Machin SJ. A flow-cytometric approach to quantitative estimation of platelet surface immunoglobulin G. Vox Sang 1993;64:106–15.
Stockelberg D, Hou M, Jacobsson S, et al. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELiSa. Eur J Haematol 1996;56:72–7.10.1111/j.1600-0609.1996.tb00298.x8599998
Hezard N, Simon G, Mace C, et al. Is flow cytometry accurate enough to screen platelet autoantibodies? Transfusion 2008;48:513–18.10.1111/j.1537-2995.2007.01556.x18067500
Davoren A, Bussel J, Curtis BR, et al. Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP). Am J Hematol 2005;78:193–7.10.1002/ajh.2030915726595
Kohler M, Dittmann J, Legler TJ, et al. Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching. Transfusion 1996;36:250–5.10.1046/j.1537-2995.1996.36396182144.x8604511
Skogen B, Christiansen D, Husebekk A. Flow cytometric analysis in platelet crossmatching using a platelet suspension immunofluorescence test. Transfusion 1995;35:832–6.10.1046/j.1537-2995.1995.351096026364.x7570913
Lin M, Shieh SH, Liang DC, et al. Neonatal alloimmune thrombocytopenia in Taiwan due to an antibody against a labile component of HPA-3a (Baka). Vox Sang 1995;69:336–40.
Harrison CR, Curtis BR, McFarland JG, et al. Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays. Transfusion 2003;43:1398–402.10.1046/j.1537-2995.2003.00533.x14507271
Hewitt J, Burton IE. Incidence of autoantibodies to GPIIb/IIIa in chronic autoimmune thrombocytopenic purpura may be overestimated by the MAIPA. Br J Haematol 1994;86:418–20.10.1111/j.1365-2141.1994.tb04758.x8199041
Helmberg W, Folsch B, Wagner T, Lanzer G. Detection and differentiation of platelet-specific antibodies by flow cytometry: the bead-mediated platelet assay. Transfusion 1997;37:502–6.10.1046/j.1537-2995.1997.37597293881.x9149775
Bakchoul T, Meyer O, Agaylan A, et al. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads. Transfusion 2007;47:1363–8.10.1111/j.1537-2995.2007.01274.x17655579
Fujiwara K, Shimano K, Tanaka H, et al. Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sang 2009;96:244–51.10.1111/j.1423-0410.2008.01140.x19207165
Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998;59:313–22.10.1016/S0198-8859(98)00020-2
Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992;68:95–6.10.1055/s-0038-1656329
Warkentin TE. Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies—distinguishing “signal” from “noise”. Thromb Haemost 2008;100:523–4.10.1160/TH08-08-0533
Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2008;100:678–84.10.1160/TH08-02-0118
Dellaria SM, Greilich PE, Sarode R. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test. Anesth Analg 2008;107:379–81.10.1213/ane.0b013e318172af0f18633011
Warkentin TE, Sheppard JA, Moore JC, et al. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 2005;146:341–6.10.1016/j.lab.2005.08.00316310517
Amiral J, Wolf M, Fischer A, et al. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996;92:954–9.10.1046/j.1365-2141.1996.407945.x8616093
McFarland JG, Curtis BR, Lochowicz AJ, et al. Correlation of PF4 ELISA results and clinical likelihood of HIT—can we improve on specificity? Blood 2008;(Suppl) 112:3423.10.1182/blood.V112.11.3423.3423
Hurd CM, Cavanagh G, Schuh A, et al. Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sang 2002;83:1–12.10.1046/j.1423-0410.2002.00187.x12100382
Curtis BR. Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders. Semin Thromb Hemost 2008;34:539–48.10.1055/s-0028-110336519085653
Nauck MS, Gierens H, Nauck MA, et al. Rapid genotyping of human platelet antigen 1 (HPA-1) with fluorophore-labelled hybridization probes on the LightCycler. Br J Haematol 1999;105:803–10.10.1046/j.1365-2141.1999.01427.x10354151
Randen I, Sorensen K, Killie MK, Kjeldsen-Kragh J. Rapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis. Transfusion 2003;43:445–50.10.1046/j.1537-2995.2003.00354.x12662276
Kjaer KM, Jaegtvik S, Husebekk A, Skogen B. Human platelet antigen 1 (HPA 1) genotyping with 5′ nuclease assay and sequence-specific primers reveals a single nucleotide deletion in intron 2 of the HPA 1a allele of platelet glycoprotein IIIa. Br J Haematol 2002;117:405–8.10.1046/j.1365-2141.2002.03454.x11972525
Bugert P, McBride S, Smith G, et al. Microarray-based genotyping for blood groups: comparison of gene array and 5’-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005;45:654–9.10.1111/j.1537-2995.2005.04318.x15847651
de Haasa M, van der Schoota CE, Beiboera SHW, et al. Red blood cell and platelet genotyping: from current practice to future high-throughput donor typing. Transfus Med Hemother 2006;33:260–6.10.1159/000092582
Curtis BR, Fick A, Lochowicz AJ, et al. Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B. Transfusion 2008;48:358–64.
Garritsen HS, Fan AX, Bosse N, et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for genotyping of human platelet-specific antigens. Transfusion 2009;49:252–8.10.1111/j.1537-2995.2008.01953.x18980617
Bertrand G, Bianchi F, Chenet C, et al. New mutation in the platelet beta3-integrin gene: implication for the diagnosis of fetomaternal alloimmunization. Transfusion 2006;46:2138–41.10.1111/j.1537-2995.2006.01043.x17176326
Skogen B, Wang R, McFarland JG, Newman PJ. A dinucleotide deletion in exon 4 of the PlA2 allelic form of glycoprotein IIIa: implications for the correlation of serologic versus genotypic analysis of human platelet alloantigens. Blood 1996;88:3831–6.10.1182/blood.V88.10.3831.bloodjournal88103831
Smith GA, Rankin A, Riddle C, et al. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele. Vox Sang 2007;93:325–30.10.1111/j.1423-0410.2007.00968.x18070277